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1. Introduction 
Kinetic solvent deuterium isotope effects on the 
rates of alkylation of the active site sulfhydryl group 
of papain have been used as a probe of the mechanism 
by which this relatively simple nucleophilic process is 
catalyzed in the pH range where the enzyme is opti- 
mally active with substrates (pH E 5-7). As evidence 
against general base catalysis, unity isotope effects 
were reported on the rates of alkylation by methyl- 
bromoacetate and by chloroacetamide [ 1,2]. On the 
other hand, this interpretation is complicated by the 
reported inverse isotope effects on the rates of alkyla- 
tion by bromoacetamide (k(H,O)/k(D,O) = 0.74)and 
by chloroacetate (k(H,O)/k(D,O) = 0.75) [ 1,3]. The 
possibility has been suggested that observed inverse 
kinetic isotope effects could arise from preferential 
reaction of these alkylating agents with the proposed 
active site thiolate-imidazolium ion pair, formed 
between the active site sulfhydryl group and a neigh- 
boring imidazole function, provided that the tauto- 
merization equilibrium constant (K) controlling the 
relative concentrations of ion pair (II) and its tauto- 
mer (I) is -2 in HzO, eq. (1) [4]: 
K \ HN-~H - S 
(1) 
(I) (11) 
Thus, observed inverse kinetic isotope effects could 
originate from an equilibrium solvent deuterium iso- 
tope effect on K, estimated to be inverse from the 
isotopic fractionation factors of the S-H (@J = 0.4) 
and N-H ($J = 1 .O) bonds, K(HaO)/K(D,O) = 
As a test of whether it is chemically reasonable to 
attribute any or all of the observed kinetic solvent 
deuterium isotope effects reported on papain to the 
fundamental properties of the tautomerization equi- 
librium shown in eq. (l), the magnitudes of the sol- 
vent deuterium isotope effects on the rates of alkyla- 
tion of the tautomeric forms of cysteine and /3-mercap- 
toethylamine were determined for bromo- and chloro- 
acetate, bromo- and chloroacetamide, as well as for 
methylbromoacetate. These thiolamines are viewed as 
elementary chemical models of the sulfhydryl group 
tautomerization equilibrium envisioned in the active 
site of papain. 
2. Materials and methods 
LCysteine hydrochloride monohydrate (Sigma) 
was used without further purification. /3-Mercaptoeth- 
ylamine hydrochloride (Evans Chemetics) was twice 
recrystallized from warm 1 -propanol. Methylbromo- 
acetate (Eastman) and bromoacetamide (Pfaltz) were 
used without further purification. 
All kinetic measurements were made on a Gilford 
2400-2 spectrophotometer equipped with a thermo- 
statted cuvette carriage. The rates of reaction of alky- 
lating agents with the thiolamines were determined as 
a function of pL in Hz0 or D,O from the rate of loss 
of mercaptide ion Aa5,, in argon saturated phosphate- 
borate-acetate buffers, ionic strength adjusted with 
Abbreviation: L, hydrogen ion or deuterium ion 
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NaCl. Pseudo-first order conditions were used in all 
cases. The observed pseudo-first order rate constants 
had to be corrected for a small first order loss of mer- 
captide ion absorbancy determined in the absence of 
alkylating agent. In the case of the brominated alky- 
lating agents this correction was 52% of the observed 
pseudo-first order rate constants, while for the chlori- 
nated alkyiating agents the correction was typicaily 
from 4-l 0% of the observed pseudo-first order rate 
constants. 
Potentiometric titrations of the thiol~ines were 
carried out on a TTT40 Titrator (Radiometer, 
Copenhagen) equipped with an ABU 12 Autoburette. 
Samples were maintained under argon in the presence 
of 0.1 mM EDTA during titration with NaOL in Hz0 
or DaO. Ionic strength was maintained with 0.084 M 
NaCl. 
All pD values were calculated as being equal to the 
pH-meter eading plus 0.4. 
3. Results 
The pL-dependence of the observed second order 
rate constants for reaction of alkylating agents with 
cysteine and P-mercaptoethylamine is described by 
eq. (2): 
kObS = (2) 
derived from scheme (1) in which R = CO; for cys- 
teine and R = H for ~-mercaptoethylam~e; I = alky- 
lating agent and P = alkylated thiolamine. The solvent 
deuterium isotope effect on kybS is most important 
for comparison with the kinetic solvent deuterium 
isotope effects reported with papain since this is the 
second order rate constant for reaction with the sum 
of the tautomeric forms, 2 and 3. Fig.1 shows the 
experiment~ly determined pL-dependencies of kobS 
using bromoacetate as an alkylating agent. The ascend- 
ing limbs of the curves from pL N 7-10 reflect the 
conversion of unreactive 1 to 2 plus 3, while the 
descending limbs of the curves (PL > 10) reflect the 
conversion of 2 plus 3_ to 2. In order to simplify the 
i 
~-merc~toethylamine 
Fig.1. The pL dependence of the second order rate constants 
for alkylation of cysteine and ~~ercaptoe~y~m~e by 
bromoacetate in H,O and D,O (99%), 25°C. Pseudo-first 
order conditions were used for all determinations; cysteine 
and ~-mercaptoe~yiam~e were 0.1-0.2 mM while bromo- 
acetate was 2-4 mM, depending on the pL. A wide range 
phosphate-borate-acetate buffer (16 mM in each buffer 
component) was used to maintain pL while NaCl was used to 
maintain ionic strength at 0.084 M. 
R 
HH: 
-lJ+ 
\ )P 
SH KA 
(l> 
Scheme 1 
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Table 1 
Kinetically and potentiometrically determined macroscopic ionization constants for cysteine 
and P-mercaptoethylaminein H,O and D,O and the kinetic solvent deuterium isotope effects 
on the rates of alkylation of the pi-dependent forms of these thiolamines by bromoacetate 
Parameter Method Cysteine in p-Mercaptoethylamine in
Hz0 D,O Hz0 D,O 
pRA PO tent. titr .a 8.10 8.59 8.34 8.68 
pKB Potent. titr.a 10.49 10.89 10.84 11.38 
k&M- s-r) 0.082 N NaOLb 1.11 1.03 1.47 1.34 
(& (H, 0% (D,oH (1 .OS> (1.10) 
pKA Curve fitC 8.03 8.66 8.34 8.58 
kpbs(M-‘s-rj Curve fitC I .OP 1.41 1.89 1.81 
(k, (H&W, (D,W (0.77) (1.04) 
a Potentiometric titration of thiolamines in 0.084 M NaCl, 0.1 mM EDTA, 25°C. Na’ cor- 
rectionappliedabove pL 10.50.Estimated error from repetitive titrations is r0.05 pK units 
b Determined from the t~edependent loss of mercaptide ion A,, under pseudo-first order 
conditions, [thio~m~e] = 0.1 mM; [bromoacetatef = 2 mM in 0.082 N NaOH (in H,O) 
and in 0.082 N NaOD (in D,O). Ionic strength due to base plus bromoacetate is 0.084 M 
c Best fit valves to the data of fig.1 using a least squares iterative computer program based 
on eq. (2) in which plYR and k, were held fixed at the potentiometrically and kinetically 
determined values ho& in the table 
problem of determ~~g kybs by computer fitting 
eq. (2) to the data of fig.1, the foliowing procedure 
was used: 
(0 
(ii) 
The macroscopic ionization constants for each of 
the thiolam~es, pKA and pKB, were determined 
potentiometrically in HZ0 and DsO in the pres- 
ence of 0,084 M NaCl and 0.1 mM EDTA, table 1. 
The values of k2 for reaction of bromoacetate 
with form $_ of the thiolamines were determined 
in strong base in H20 and DzO, table 1. The val- 
ues of kz and KB so determined were then held 
constant in a computer program based on eq. (2) 
which iterated about the values of KA and kybs 
until the least squares best fit values were found. 
The solid lines through the data of fig.1 are the 
least squares best fit lines obtained by this proce- 
dure; table 1 shows the best fit values for kTbs 
and KA determined in Hz0 and DzO. 
For bromoacetamide and me~ylbromoacetate 
complete pl-alkylation rate profiles could not be 
obtained because of the rapid rates of hydrolysis of 
these compounds above pL = 9.5 _ Thus, the isotope 
effect on kybs was calculated from kobs values deter- 
mined in Hz0 and DsO at relatively low pL 
(Kn/[L+] Q 1) where eq. (2) effectively reduces to 
eq. (3): 
July 1980 
obs 
kobs = kr 
[L+lK, + 1 
(3) 
In practice, 3-5 repetitive measurements of kobs were 
made in Hz0 at pH = 8-8.4 and 3-5 repetitive mea- 
surements of kobs were made in DzO at pD = 8.2-8.6. 
To increase the comparative precision of these mea- 
surements, they were made on the same day using the 
same concentrated stock solution of alkylating agent 
dissolved in 50% H,O/50% DzO. At the stock concen- 
trations of alkylat~ng agent used, an insigni~c~t 1% 
DzO was introduced into the Hz0 run and an insignifi- 
cant 1% Hz0 was introduced into the DsO run. Finally, 
kybs in each of the solvents was calculated using 
eq. (3) together with the k~etjc~y detested values 
of K, obtained from the computer fit to the complete 
alkylation rate profiles for cysteine and @-mercapto- 
e~ylam~e by bromoacetate, table I. Application of 
this procedure to bromoacetate gave values of k(iibs in 
Hz0 and in DzO in close agreement with those deter- 
mined from the curve fitting procedure, table 2. 
Table 2 also summa~zes the solvent deuterium isotope 
effects on kybs, and the corresponding standard devia- 
tions, determined by this method for bromoacetamide 
and methylbromoacetate as well as for chloroacet- 
amide and chloroacetate. 
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Tabfe 2 
Solvent deuterium isotope effects on k, Ohs for cysteine and P-mercaptoethylamine with different 
alkylating agentsa 
Thiolamme Alkylating agent kybs(M-r s“) in kobs(H, 0) 1 
GO W PbS(D 1 2 0) 
Cysteine bromoacetateb 1.03 f 0.02 1.46 f 0.03 
p_Merc. bromoacetateb 
0.70 i 0.02 
1.97 f 0.05 1.85 f 0.08 1.06 rf 0.05 
Cysteine chloroacetateC 0.011 * 0.001 0.013 f 0.001 0.85 * 0.10 
@-Mere. chloroacetateC 0.028 f 0.002 0.030 * 0.002 0.93 * 0.07 
Cysteine bromoacetamideb 5.71 + 0.10 8.34 + 0.05 0.69 +i 0.01 
p-Mere. bromoa~tamideb 8.79 + 0.32 7.54 -f 0.28 1.17 f 0.06 
Cysteine chloroacetamideC 0.061 + 0.003 0.096 f 0.003 0.64 t 0.04 
pMerc. chloroacetamideC 0.169 f 0.006 0.157 f 0.001 1.08 f 0.04 
Cysteine methylbromoacetated 25.8 t 1.2 48.6 + 1.1 
@-Mere. methylbromoacetated 
0.53 + 0.03 
42.6 + 1.9 43.0 + 2.5 0.99 f 0.06 
-- 
a Calculated with eq. (3) from 3-5 repetitive determinations of the observed second order rate constants 
in H,O at pH y 8-8.4 and 3-5 repetitive determinations in D,O at pD 8.2-8.6,25”C. The values of 
KA used for the calculation in Hz0 and D,O were held constant at the kineticafly determined values 
shown in table 1. A wide range phosphate-borate-acetate buffer (16 mM in each buffer component) 
was used to maintain pL white NaCl was used to maintain ionic strength at 0.084 M 
b [Thiolamine] = 0.2 mM; [alkylating agent] = 4 mM 
c [Thiolamine] = 1 .O mM; [alkylating agent] = 40 mM 
d [Thioiamine] = 0.1 mM; [alkylating agent] = 2 mM 
4. Discussion 
Kinetic solvent deuterium isotope effects on the 
limiting observed rate constant for alkyiation of the 
tautomeric forms of cysteine and P-mercaptoethyl- 
amine, kTbs , must be minimally determined by eq. (4) 
in which superscripts H and D refer to rate constants 
in Hz0 and DsO solvent: 
kybs(Hzo) k! + kFK% 
k:bs(D20) = k? + kfdj 
(41 
The equation is derived from reaction scheme (2) in 
which I is alkylating agent, P is alkylated thiolam~e, 
K32 = [z]/[ 31 and R = CO; and R = H for cysteine 
and P-mercaptoethylamine, respectively: 
The isotope effects on kybs for both cysteine and 
fl-mercaptoethylamine with a variety of different alky- 
lating agents are fully consistent with 2 being the 
reactive form towards alkylation (k, % k3), table 2. 
In the case of cysteine, the isotope effects are uni- 
formly inverse in the range 0.53 f 0.03 to 0.85 + 0.10 
with rate constants that vary over 3 orders of magni- 
tude . This range ncompasses a predicted isotope 
effect of -0.8 calculated from eq. (4) under condi- 
tions where k, 9 k3, kr/kf z 1 and given that K$ =Z 2 
and KF2 N 5, as estimated from the spectrophotometric 
titration of cysteine in Hz0 and D20 [4]. For /3-mer- 
captoethylamine an inverse isotope effect on kybs is 
not expected since 2 predominates over 3_ such that 
K3s % 1 f4]. Under these conditions eq. (4) reduces 
to. k~bs~20)~k~bs(D20) IV ky/kf when kl 3 k3. 
Thus, the isotope effect on kybs should only reflect 
Scheme 2 
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the intrinsic isotope effect on the rate of alkylation controlled by an inverse isotope effect on the tauto- 
of the mercaptide ion containing form, 2. This isotope merization equilibrium constant, which in Hz0 is -2 
effect is anticipated to be near unity since no apparent as first suggested in [3,4]. On the other hand, the 
proton transfers are involved in the alkylation of 2. near unity isotope effects on kybs for alkylation of 
The isotope effects on /cybs listed in table 2 for &mer- papain by methylbromoacetate and chloroacetamide 
captoethylamine are fully consistent with this expec- 
tation,k~bs(HaO)/k~bs(D,O)= 0.93 f 0.07 to 
are modeled by the near unity isotope effects on kybs 
for reaction of P-mercaptoethylamine with these alky- 
1.17 f 0.06. Likewise, the isotope effects on the rates lating agents and conforms to the active site conditions 
of alkylation of form 2 of cysteine and &mercapto- suggested ]6] in which the tautomerization equilibrium 
ethylamine are near unity, table 1. Finally, fig.1 constant for the enzyme is large, K = 8-12. The pos- 
graphically illustrates the basic kinetic differences sibility has been suggested that observed unity isotope 
between cysteine and P-mercaptoethylamine towards effects with the enzyme could in some cases be the 
alkylation. For cysteine, in the range pL 9- 11, the 
larger observed rate constants, kobs, in DzO compared 
result of a significant degree of reaction of the alky- 
lating agent with the thiol-imidazole tautomer , thus, 
to those in Ha0 reflect the inverse equilibrium isotope compensating for an inverse component due to an 
effect on KS2 in which 2 is the reactive form towards isotope effect on the tautomerization equilibrium 
alkylation. No such inverse kinetic isotope effect is constant of -2 in Hz0 [3]. While this possibility can- 
found for P-mercaptoethylamine since 2 already far not be excluded, there is no clear evidence for any such 
predominates over 3 in Hz0 (KS2 > 1). effect for the alkylating agents tested with cysteine. 
In view of the results of the model studies, the cen- 
tral question of interest is what explains the observed 
inverse and unity kinetic solvent deuterium isotope 
effects on the rates of alkylation of papain with these 
alkylating agents, table 3. On the one hand, the inverse 
isotope effects on k, Ohs for alkylation of papain by 
chloroacetate and bromoacetamide are modeled by 
the inverse isotope effects on kybs for alkylation of 
cysteine by these alkylating agents. This supports the 
idea that the reactive form of the enzyme is the thiol- 
ate-imidazolium ion pair whose concentration is 
The primary difficulty with drawing conclusions 
based on direct comparisons between papain and the 
model thiolamines is that the isotope effects observed 
with the enzyme are almost surely under more com- 
plex kinetic control than the isotope effects observed 
with the thiolamines. This is indicated by two major 
differences betweenthe thiolamine system and papain: 
(1) The isotope effects of kybs for the enzyme are 
neither uniformly inverse nor uniformly near one, 
table 3. 
(2) The order of reactivities of the alkylating agents 
Table 3 
Comparisons between the kinetic solvent deuterium isotope effects on the rates of alkylation of the tautomeric forms of cysteine 
and of papain with various alkylating agents 
Alkylating reagent 
Chloroacetate 
(kobs(H O)/kobs(D 0)) 
Chloroaietamfde 
1 
(kobs(H O)/kobs(D 0)) I * 1 2 
Bromoacetamide 
(kobs(H O)/kobs(D 0)) 
M~thylb:omo~cetat~ 
(kobs(H O)/kobS(D 0)) 1 1 I 2 
Limiting rate constant, Ic$‘~~(M-’ s-‘) for 
Cysteine in Papain in 
Hz0 D,O Hz0 D,O 
0.011 f 0.001 0.013 * 0.001 2.35 * 0.12 3.15 * 0.12 
(0.85 + o.lo)a (0.75 * 0.07)b 
0.061 + 0.003 0.096 i- 0.003 0.083 0.083 
(0.64 f 0 .04)a (1 .O)C 
5.71 * 0.10 8.34 * 0.05 7.0 8.1 
(0.69 r O.O1)a (0.74)d 
25.8 * 1.2 48.6 * 1.1 3.5 3.5 
(0.53 * 0.03)a (l.O)d 
a This work: conditions as shown in table 2 
b Conditions: phosphate-borate-acetate buffer (40 mM in each buffer component), ionic strength = 0.32 M, 25°C [3] 
c Conditions: ionic strength = 0.07 M, 25°C [2] 
d Conditions: ionic strength = 0.09 M, 25°C [l] 
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with the thiolamines are reversed in comparison 
with papain. 
For example, kybs for reaction of chloroacetate with 
papain is -200-fold larger than kybs for reaction of 
this alkylating agent cysteine, while kybs for reaction 
of methylbromoacetate with papain is -7-fold smaller 
than kybs for reaction of this alkylating agent with 
cysteine, table 3. These differences might be under- 
standable, if preequilibrium formation of an initial 
complex (C)between the ion pair form of papain (II) 
and alkylating agent were a central kinetic feature of 
the overall alkylation process: 
K 
I - II 
kf[Il k’, 
-C--,P --- 
kr 
In this case, kybs , is now a complex function of kinetic 
constants, eq. (5): 
I (5) 
Thus, the magnitude of the isotope effect on kybs is 
controlled not only by the equilibrium isotope effect 
on K and its absolute magnitude but also by potential 
isotope effects on the remaining kinetic constants and 
their absolute magnitudes, eq. (6): 
kybs (H,O) 
kybs (DzO) 
Under only one condition does eq. (6) reduce to a 
relatively simple form; namely, when the rate constant 
for alkylation in the complex (C) is large compared to 
the dissociation rate constant (kfl S k,), eq. (7): 
This fact could provide an explanation for the lack of 
uniformity of the isotope effects on kybs for the 
enzyme with different alkylating agents. For example, 
the isotope effect on kybs for alkylation of papain by 
chloroacetamide has been reported to be unity while 
that for bromoacetamide is inverse, table 3. The obser- 
vation that kybs for bromoacetamide is nearly lOO- 
times larger than that for chloroacetamide is most 
reasonably attributed to a much larger value of k; for 
the former alkylating agent, eq. (5). Thus, eq. (7) 
may apply in the case of alkylation of papain by 
bromoacetamide such that the observed inverse iso- 
tope effect on kybs reflects inverse isotope effects on 
the binding rate constant (kf) and/or the equilibrium 
terms of eq.(7). The near unity isotope effect on kybs 
for the slower alkylating agent, chloroacetamide, 
would be comprehensible if eq. (6) describes the alky- 
lation process such that a small normal isotope effect 
on k; and/or a small inverse isotope effect on k, can- 
cels the inverse contribution due to the equilibrium 
terms of eq. (6). By this reasoning, the observed 
inverse isotope effect on the alkylation rate of papain 
by chloroacetate would reflect ki S k, while the unity 
isotope effect with methylbromoacetate would reflect 
k: 5 k,. This tentative conclusion seems reasonable in 
view of the possibility that electrostatic association 
between chloroacetate and the thiolate-imidazolium 
ion pair could be a primary factor in reducing the rate 
of dissociation from the enzyme. 
In summary, the results of the model studies 
reported here emphasize the potential importance of 
inverse solvent deuterium isotope effects on the active 
site tautomerization equilibrium of papain as being 
the source of observed inverse kinetic solvent deute- 
rium isotope effects found with some alkylating agents 
near neutral pL. However, it must be emphasized, 
that observed isotope effects with the enzyme are 
under relatively complex kinetic control compared to 
the model thiolamine systems, and therefore, alterna- 
tive interpretations are possible. 
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